Drug Rights

All articles by Drug Rights

AstraZeneca buys rights to GLP-1 drug from Eccogene for $185M upfront

Jack O'Brien

November 9, 2023

12:24 pm

In addition to the GLP-1 play, AstraZeneca also released its most recent earnings report Thursday morning.

From Our Partners

Partner Content

How AI and first-party data is transforming pharma customer engagement

Using technology to improve audience segmentation, targeting and virtual interaction.

Partner Content

The importance of female representation in health

How to effect change and close the gender gap in healthcare.

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization.

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

This session with Justin Freid, chief marketing and innovation officer of CMI Media Group, and Daniel Nadler, founder of Open Evidence, will enlighten health brands to the possibilities of AI.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Drug Rights

All articles by Drug Rights

AstraZeneca buys rights to GLP-1 drug from Eccogene for $185M upfront

AI Deciphered: Discovering the Potential for Marketers and Communicators

From Our Partners

Partner Content

How AI and first-party data is transforming pharma customer engagement

Partner Content

The importance of female representation in health

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs